Cargando…

Rituximab depletion of intrahepatic B cells to control refractory hepatic autoimmune overlap syndrome

Detalles Bibliográficos
Autores principales:	Appanna, G D, Pembroke, T P I, Miners, K L, Price, D A, Gallimore, A M, Ladell, K, Godkin, A J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783609/ https://www.ncbi.nlm.nih.gov/pubmed/31243454 http://dx.doi.org/10.1093/qjmed/hcz161

Ejemplares similares

Tracking the kinetics of intrahepatic immune responses by repeated fine needle aspiration of the liver
por: Pembroke, Tom, et al.
Publicado: (2015)

Treatment of Refractory Pediatric Autoimmune Hepatitis With Rituximab
por: Saul, Samantha A., et al.
Publicado: (2021)

Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group
por: Than, Nwe Ni, et al.
Publicado: (2019)

The paradox of NKp46(+) natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment
por: Pembroke, Tom, et al.
Publicado: (2014)

Highly prevalent colorectal cancer-infiltrating LAP(+) Foxp3(−) T cells exhibit more potent immunosuppressive activity than Foxp3(+) regulatory T cells
por: Scurr, M, et al.
Publicado: (2014)

Steroid-Refractory Insulin Autoimmune Syndrome Treated With Rituximab and Continuous Glucose Monitoring
por: Batra, Chandar M, et al.
Publicado: (2021)

A Patient of Lupus Presenting with Myocarditis and Overlapping Autoimmune Hepatitis
por: Chattopadhyay, P., et al.
Publicado: (2011)

A Case of Autoimmune Hepatitis Treated with Rituximab
por: Barth, E., et al.
Publicado: (2010)

The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders
por: Papamichalis, Panagiotis A, et al.
Publicado: (2007)

Long term survival of cirrhotics following admission to a uk intensive care unit - a subgroup of patients with ´resilient´ cirrhosis
por: Lloyd-Evans, J, et al.
Publicado: (2015)

Rituximab for the treatment of refractory pediatric autoimmune diseases: a case series
por: Tzaribachev, Nikolay, et al.
Publicado: (2009)

Rituximab Therapy for Refractory Autoimmune Thrombocytopenia in Patients with Systemic Lupus Erythematosus
por: Atay, Didem, et al.
Publicado: (2012)

Prolonged B Cell Depletion With Rituximab is Effective in Treating Refractory Pulmonary Granulomatous Inflammation in Granulomatosis With Polyangiitis (GPA)
por: Henderson, Scott R., et al.
Publicado: (2014)

Enhanced Detection of Antigen-Specific CD4(+) T Cells Using Altered Peptide Flanking Residue Peptide–MHC Class II Multimers
por: Holland, Christopher J., et al.
Publicado: (2015)

Long-term safety of rituximab induced peripheral B-cell depletion in autoimmune neurological diseases
por: Memon, Anza B., et al.
Publicado: (2018)

CD3ζ-based chimeric antigen receptors mediate T cell activation via cis- and trans-signalling mechanisms: implications for optimization of receptor structure for adoptive cell therapy
por: Bridgeman, J S, et al.
Publicado: (2014)

New scoring classification for primary biliary cholangitis–autoimmune hepatitis overlap syndrome
por: Zhang, Wei, et al.
Publicado: (2018)

Reply: Forkhead box P3-positive regulatory T cells in immune surveillance and cancer
por: Betts, G, et al.
Publicado: (2007)

Utilization of Rituximab for Refractory Rowell Syndrome
por: Singh, Sukhraj, et al.
Publicado: (2021)

Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4(+) T-cell immunity
por: Pembroke, Tom, et al.
Publicado: (2012)

Progression of carcinogen‐induced fibrosarcomas is associated with the accumulation of naïve CD4+ T cells via blood vessels and lymphatics
por: Ondondo, Beatrice, et al.
Publicado: (2013)

Development of systemic sclerosis in patients with autoimmune hepatitis: an emerging overlap syndrome
por: Assandri, Roberto, et al.
Publicado: (2016)

Hunting for clues: Regulatory T cells and colorectal cancer
por: Gallimore, Awen, et al.
Publicado: (2012)

Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody
por: Bai, Yunfei, et al.
Publicado: (2023)

Successfully Treated Hepatitis B Positive Refractory Myasthenic Crisis with Rituximab
por: Singh, R Kumar, et al.
Publicado: (2020)

Refractory Sweet's syndrome successfully treated with rituximab
por: Seminario-Vidal, Lucia, et al.
Publicado: (2015)

Successful Treatment for Chronic Hepatitis C-Autoimmune Hepatitis Overlap Syndrome due to Daclatasvir and Asunaprevir
por: Sugiura, Ayumi, et al.
Publicado: (2017)

Association of an overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis with cytomegalovirus infection
por: Toyoda-Akui, Megumi, et al.
Publicado: (2011)

Characteristics and Inpatient Outcomes of Primary Biliary Cholangitis and Autoimmune Hepatitis Overlap Syndrome
por: Jiang, Yi, et al.
Publicado: (2021)

Primary Sclerosing Cholangitis and Autoimmune Hepatitis Overlapping Syndrome Complicated by Ulcerative Colitis
por: Suzuki, Takanori, et al.
Publicado: (2022)

Yellow urticaria revealing overlap syndrome of autoimmune hepatitis and primary biliary cholangitis
por: Toujani, Sana, et al.
Publicado: (2023)

Autoimmune hepatitis and primary biliary cholangitis overlap syndrome after COVID-19
por: Cunha-Silva, Marlone, et al.
Publicado: (2023)

Update on the role of venetoclax and rituximab in the treatment of relapsed or refractory CLL
por: D’Rozario, James, et al.
Publicado: (2019)

Rituximab: B cell depletion: case report
Publicado: (2021)

Pathology of rituximab-induced Kaposi sarcoma flare: role of B-cell depletion
por: Pantanowitz, L, et al.
Publicado: (2009)

Steroid Refractory Autoimmune Haemolytic Anaemia Secondary to Sarcoidosis Successfully Treated with Rituximab and Mycophenolate Mofetil
por: Green, Sarah, et al.
Publicado: (2016)

Case Report: Ofatumumab treatment in a patient with rituximab-intolerant refractory autoimmune GFAP astrocytopathy
por: Cao, Shugang, et al.
Publicado: (2023)

Direct intrahepatic portocaval shunt for refractory hepatic hydrothorax: a case report
por: Kawahara, Yo, et al.
Publicado: (2016)

Unique Method of Transjugular Intrahepatic Portosystemic Shunt Reduction for Refractory Hepatic Encephalopathy
por: Khan, Ayub, et al.
Publicado: (2021)

Rituximab for Autoimmune Encephalitis with Epilepsy
por: Kurukumbi, Mohankumar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qn7etmqsp148u4o0svcbn3apl9